Europe Pharmaceutical Robots Market Key Players and Opportunities by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Europe Pharmaceutical Robots Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Collaborative Pharmaceutical Robots and Traditional Robots), Application (Inspection of Pharmaceutical Drugs, Laboratory Applications, and Picking and Packaging), and End User (Pharmaceutical Companies, Research Laboratories, and Contract Research Organizations)

  • Report Date : Nov 2021
  • Report Code : TIPRE00025566
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 135
Page Updated: Nov 2021

The Europe pharmaceutical robots market is expected to grow from US$ 40.45 million in 2021 to US$ 95.30 million by 2028; it is estimated to grow at a CAGR of 13.0% from 2021 to 2028.



Pharmaceutical and biotechnology companies focus on research and development (R&D) to develop new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies invest large amounts in R&Ds to deliver high-quality and innovative products to the market. Drug development and discovery are time-consuming and expensive processes. However, pharmaceutical robots help pharmaceutical companies reduce costs and increase efficiency in the drug discovery process. Many repetitive tasks, such as moving fluids and test tubes, are performed in the research and development of drugs. In such a scenario, robots are used to automate the process as they offer a high level of accuracy and consistency. As a result, scientists can avoid menial tasks and focus on more meaningful activities, such as drug development research. Therefore, the increasing expenditure on research and development in pharmaceutical and biotechnology companies to save cost and time and to improve the drug discovery process propels the growth of the pharmaceutical robots market.
 

As the coronavirus cases increase in the area, many countries are fighting to control the disease's spread. Artificial intelligence (AI) and machine learning represent a crucial part in better knowing and discussing the COVID-19 crisis. Machine learning technology permits computers to mimic human intelligence and ingest large volumes of data to identify patterns and insights quickly. In the fight toward COVID-19, associations have been instantaneous to utilize their machine learning expertise in several areas, such as scaling customer connections and knowing COVID-19 spreads and speeds up research and medication. The researchers recorded an elevated selection and use of AI in scientific and medical research, particularly in applications such as medical diagnosis, telemedicine, epidemiological studies, and clinical management of patients. There was also a shift in approaches towards AI and data distribution. According to the study, the crisis occurred in a comprehensive agreement of robots in the workplace and data distribution to monitor the virus's spread. In March 2020, Robotiq launched a pandemic initiative called Cobots vs. COVID. The program aims to help essential goods manufacturers such as medical equipment, pharmaceuticals, and others, rapidly increase their production by deploying cobot cells.  Such initiatives in the region open a window of opportunities for the market players involved in the pharmaceutical robots market.
 

With the new advancements and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe pharmaceutical robots market. Several conferences, workshops, and exhibitions are being held across the region to spread the awareness of robotic systems. For instance, GlaxoSmithKline, has collaborated with other pharmaceutical companies to assess the robotic platforms for precise, automated dispensing of solids and AstraZeneca has worked on combined efforts to improve the measurement and prediction of active pharmaceutical ingredient (API) solubility. Also, the Digital Robot Pharma Fab Workshop was held in June 2019 in Amsterdam, The Netherlands. The workshop demonstrated the applications of robotics in the pharmaceutical industry and introduced the advantages and risks associated with it. The workshop included lectures and hands-on training by mock-ups and live activities presented in the exhibition hall. Moreover, on April 20–21, 2021, Scientific Program Planning Committee and Parenteral Drug Association (PDA) Europe held PDA Robotics and Automation Conference, a virtual event. Its theme was “Challenges and Opportunities of Robotics and Automation—A Paradigm Shift within the Pharma Industry”. Thus, the growing conferences, workshops, and exhibitions to create awareness regarding pharmaceutical robots propel the growth of the pharmaceutical robots market in Europe.
 25252-img1
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Europe Pharmaceutical Robots Market Segmentation

  • Europe Pharmaceutical Robots Market – By Product
    • Collaborative Pharmaceutical Robots
    • Traditional Robots
  • Europe Pharmaceutical Robots Market – By Application
    • Inspection of Pharmaceutical Drugs
    • Laboratory Applications
    • Picking and Packaging
  • Europe Pharmaceutical Robots Market – By End User
    • Pharmaceutical Companies
    • Research Laboratories
    • Contract Research Organizations
  • Europe Pharmaceutical Robots Market – By Country
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe

Europe Pharmaceutical Robots Report Scope

Report Attribute Details
Market size in 2021 US$ 40.45 Million
Market Size by 2028 US$ 95.30 Million
Global CAGR (2021 - 2028) 13.0%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Collaborative Pharmaceutical Robots and Traditional Robots
By Application
  • Inspection of Pharmaceutical Drugs
  • Laboratory Applications
  • Picking and Packaging
By End User
  • Pharmaceutical Companies
  • Research Laboratories
  • Contract Research Organizations
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • ABB
  • Kawasaki Heavy Industries, Ltd.
  • YASKAWA ELECTRIC CORPORATION
  • Universal Robots
  • Marchesini Group S.p.A
  • DENSO Corporation
  • FANUC CORPORATION
  • Seiko Epson Corporation
  • WEISS GmbH
  • Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Our Clients
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo